Equity research swarm on an investment thesis

Context

A markets research desk drafts a thesis on a covered name ahead of an earnings print. A research agent assembles filings, transcripts, and consensus; a risk agent stress tests the downside and the crowded trade angle; a writer drafts the note; and a compliance critic checks every claim for MNPI, selective disclosure, and unsupported price target language.

The decision

The compliance critic is non negotiable in a regulated research function, it's a surveillance control, not a nicety. That's what justifies the multiagent cost here.

What most miss

In markets the risk isn't a weak thesis, it's a well argued note that trips a disclosure or MNPI line. The critic is the control that keeps research publishable.

Stakes

A single compliance slip in published research is a regulatory and franchise event; the inference cost is a rounding error against it.